Hacker Karen
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Mayo Clin Proc Innov Qual Outcomes. 2024 Jan 20;8(1):112-119. doi: 10.1016/j.mayocpiqo.2023.08.005. eCollection 2024 Feb.
Chronic diseases like diabetes, heart disease, stroke, and cancer have been and continue to be some of the major causes of worldwide morbidity and mortality. A transition between infectious and noncommunicable diseases occurred in the early 1900s as a result of improved public health and has persisted ever since. Now, as individuals live longer, the prevalence and cost of chronic disease continue to grow. The estimated cost of chronic disease is expected to reach $47 trillion worldwide by 2030. Individual lifestyle and behaviors and community factors play important roles in the development and management of chronic diseases. Many of these conditions (diabetes, heart disease, and respiratory diseases) are preventable, and their leading risk factors are physical inactivity, poor nutrition, tobacco use, and excessive alcohol. Unfortunately, the investment in prevention remains small compared with treatment, both from a lifestyle perspective and a social determinants of health perspective. Given the future trajectory of chronic disease, innovation in technology and pharmaceuticals with a concomitant investment in prevention will be required. Our future depends on it.
糖尿病、心脏病、中风和癌症等慢性病一直是并将继续是全球发病和死亡的一些主要原因。由于公共卫生状况改善,20世纪初发生了从传染病到非传染病的转变,此后一直持续。如今,随着人们寿命延长,慢性病的患病率和成本持续上升。预计到2030年,全球慢性病成本将达到47万亿美元。个人生活方式和行为以及社区因素在慢性病的发生和管理中起着重要作用。这些疾病(糖尿病、心脏病和呼吸系统疾病)中的许多是可以预防的,其主要风险因素是缺乏身体活动、营养不良、吸烟和过量饮酒。不幸的是,无论是从生活方式角度还是从健康的社会决定因素角度来看,与治疗相比,预防方面的投资仍然很少。鉴于慢性病的未来发展趋势,需要在技术和制药方面进行创新,并同时投资于预防。我们的未来取决于此。